Showing 1 - 8 results of 8 for search 'Dafna D Gladman', query time: 0.02s
Refine Results
-
1
Single-cell RNA sequencing of circulating immune cells supports inhibition of TNFAIP3 and NFKBIA translation as psoriatic arthritis biomarkers by Ameth N. Garrido, Rohan Machhar, Omar F. Cruz-Correa, Darshini Ganatra, Sarah Q. Crome, Sarah Q. Crome, Joan Wither, Joan Wither, Joan Wither, Igor Jurisica, Igor Jurisica, Igor Jurisica, Dafna D. Gladman, Dafna D. Gladman, Dafna D. Gladman
Published 2025-02-01Get full text
Article -
2
Chronic kidney disease in patients with psoriatic arthritis: a cohort study by Dafna D Gladman, Vinod Chandran, Richard J Cook, Fadi Kharouf, Shangyi Gao, Shahad Al-Matar
Published 2024-11-01Get full text
Article -
3
-
4
Efficacy and safety of tofacitinib in an open-label, long-term extension study in patients with psoriatic arthritis who received adalimumab or tofacitinib in a Phase 3 randomized c... by Dafna D. Gladman, Peter Nash, Philip J. Mease, Oliver FitzGerald, Stephanie Duench, Mary Jane Cadatal, Karim R. Masri
Published 2024-12-01Get full text
Article -
5
Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus by Murray B Urowitz, Dafna D Gladman, Jiandong Su, Zahi Touma, Paula Harvey, Jagan Sivakumaran, Ahmed Omar, Oshrat Tayer-Shifman, Nicole Anderson
Published 2021-04-01Get full text
Article -
6
Early Improvements with Guselkumab Associate with Sustained Control of Psoriatic Arthritis: Post hoc Analyses of Two Phase 3 Trials by Jeffrey R. Curtis, Atul Deodhar, Enrique R. Soriano, Emmanouil Rampakakis, May Shawi, Natalie J. Shiff, Chenglong Han, William Tillett, Dafna D. Gladman
Published 2024-09-01Get full text
Article -
7
Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status by Alexis Ogdie, Lars E. Kristensen, Enrique R. Soriano, Servet Akar, Yanhui Sun, David Gruben, Lara Fallon, Cassandra D. Kinch, Dafna D. Gladman
Published 2024-09-01Get full text
Article -
8
Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies by Ronald F van Vollenhoven, Laurent Arnaud, Marta Mosca, Nathalie Costedoat-Chalumeau, Elisabet Svenungsson, Daniel J Wallace, Judith A James, Kenneth Kalunian, Susan Manzi, Michelle A Petri, Jill Buyon, Rosalind Ramsey-Goldman, Ian N Bruce, Guillermo Ruiz-Irastorza, Ellen M Ginzler, Manuel Francisco Ugarte-Gil, Bernardo A Pons-Estel, Juanita Romero-Diaz, Sang-Cheol Bae, Anisur Rahman, Paul R Fortin, Dafna D Gladman, Andreas Jönsen, Murat Inanc, Diane L Kamen, Søren Jacobsen, Jorge Sanchez-Guerrero, Évelyne Vinet, Murray Urowitz, David Isenberg, Sasha Bernatsky, John Reynolds, Eric Morand, Vernon Farewell, Claudia Elera-Fitzcarrald, Cristina Reátegui-Sokolova, Alexandre Voskuyl, Anca D Askanase, John Hanly, Anselm Mak, Sung Sam Lim, Christine Peschken, Graciela S. Alarcon, Joanna Leong, Bhushan Dharmadhikari, Nien Yee Kow, Cinthia Aranow, Mary Ann Dooley, Mike Cheung
Published 2021-05-01Get full text
Article